Key facts
- Notable investors include Chengdu High-Tech Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Shichuang Kecai
- ·The full record, as it builds
Funding rounds
No funding rounds for Shichuang Kecai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shichuang Kecai
Developer of ophthalmic polymer devices designed to improve retinal surgical outcomes. The company offers emulsification-resistant silicone oil and hydrogel-based intraocular implants, enabling retinal specialists to manage complex vitreoretinal conditions with greater safety, stability, and therapeutic efficacy.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Shichuang Kecai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shichuang Kecai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shichuang Kecai in its N-PORT filings yet. We sweep new filings monthly.